Latest updates for Phase 3 Development

Fresh curated links around Phase 3 development are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Big Pharma-backed AdvanCell, flush with $315M series D, ready to put radiotherapy pedal to the metal
  • Compass Closes Out Phase 3 With 6-Month COMP006 Data, Eyes H1’27 Launch
  • CACI Advances to Phase 3 of SSC’s Optical Communications Terminal Development Program

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

fiercebiotech.com /1 day ago

Big Pharma-backed AdvanCell, flush with $315M series D, ready to put radiotherapy pedal to the metal

Less than a month after locking down a lease for a new U.S. headquarters, radiotherapy outfit AdvanCell is poised to push its lead prostate cancer candidate into phase 3 developmen...

Read source
psychedelicalpha.com /1 week ago

Compass Closes Out Phase 3 With 6-Month COMP006 Data, Eyes H1’27 Launch

This morning, Compass Pathways shared 26-week data from its second Phase 3 study of COMP360 psilocybin for treatment-resistant depression (TRD). The data are from Part B of COMP006...

Read source
executivebiz.com /1 month ago

CACI Advances to Phase 3 of SSC’s Optical Communications Terminal Development Program

SSC has selected CACI to move forward to Phase 3 of the Enterprise Space Terminal program CACI will build a proto-flight optical communications terminal and conduct testing Join th...

Read source
indiandefensenews.in /1 month ago

India In Elite Group With Capability To Neutralise ICBMs; Phase-III Initiated To Address Even More Complex Threats

India has successfully completed the final development trials of its Phase-II Ballistic Missile Defence (BMD) program, marking a historic milestone in the nation’s strategic defenc...

Read source
fiercebiotech.com /2 weeks ago

Vistagen fails another phase 3 social anxiety trial but spies path to market

Vistagen’s social anxiety disorder drug candidate has flunked another phase 3 trial. But, with a post hoc subpopulation analysis linking fasedienol to a nominally statistically sig...

Read source
fiercebiotech.com /1 month ago

Edgewise data power rival to BMS and Cytokinetics toward phase 3

Edgewise Therapeutics has reported phase 2 data on its cardiomyopathy prospect, keeping the biotech on track to start pivotal development of a would-be challenger to Bristol Myers...

Read source
fiercebiotech.com /6 days ago

GSK sees phase 3 win for Hansoh-partnered ADC in China as validating its ‘priority asset’

Hansoh Pharmaceutical’s pair of much-hyped ADCs continue to justify partner GSK’s decision to make them priority programs.

Read source
newswire.com /1 month ago

IGC Pharma Reaches Previously Disclosed 146-Patient Enrollment Target in Phase 2 CALMA Trial, Advancing Toward Topline A...

Company Continuing Limited Over-Enrollment Activities to Account for Attrition and Support Robust Modified Intent-to-Treat, End-of-Treatment and Exploratory Analyses

Read source
propertywire.com /1 week ago

Close Brothers finances final phase of £120m development

Close Brothers Property Finance has provided development finance for the fourth and final phase of Kingsbury Park, a £120m GDV residential scheme in Lutterworth, Leicestershire. Th...

Read source
biopharmadive.com /1 month ago

Apogee eczema drugs gets Blackstone backing, heads to Phase 3

The company made the announcement after a new round of research results bolstered the case for the experimental medicine, which may ultimately compete against Dupixent and Ebglyss.

Read source
oilandgas360.com /1 month ago

Eni approves FPSO-backed Baleine Phase 3 development

(World Oil) – Eni and its partners have approved the final investment decision for the Baleine Phase 3 offshore development in Côte […]

Read source
fiercebiotech.com /1 month ago

Apogee bags $1.3B Blackstone royalty funding deal to push eczema challenger into phase 3

Apogee Therapeutics has secured a promise of up to $1.3 billion in financing from Blackstone Life Sciences as the biotech gears up to take its anti-IL-13 antibody into phase 3.

Read source
therealdeal.com /4 weeks ago

Gotham Org files plans for next phase of East New York project

David Picket’s Gotham Organization is forging ahead with its multiphase affordable housing project in East New York. The firm filed applications for three buildings in the Brooklyn...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Phase 3 Development

oilandgas360.com

Recent coverage from public sources
Public source

blog.executivebiz.com

Recent coverage from public sources
Public source

psilocybinalpha.com

Recent coverage from public sources
Public source

therealdeal.com

Recent coverage from public sources
Public source

biopharmadive.com

Recent coverage from public sources
Public source

fiercebiotech.com

Recent coverage from public sources
Public source